S 1852 · 118th Congress · Health
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Bill Progress
✓
Introduced2
Committee3
Senate Vote4
House5
EnactedLatest: Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.(2023-09-06)
Plain Language Summary
[AI summary unavailable — showing source text]
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)…
Summarized by Claude AI · Non-partisan · For informational purposes only
CBO Cost Estimate
Congressional Budget OfficeS. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Jul 12, 2024As reported by the Senate Committee on Health, Education, Labor, and Pensions on September 6, 2023
Full CBO report ↗Official non-partisan budget analysis by the Congressional Budget Office